Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma (ViP)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2012 by Dr Gary MIddleton, University of Liverpool.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Dr Gary MIddleton, University of Liverpool
ClinicalTrials.gov Identifier:
NCT01601808
First received: February 22, 2012
Last updated: May 16, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2013
  Estimated Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)